PR Newswire
WASHINGTON, Sept. 6, 2017
WASHINGTON, Sept. 6, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda)
(NASDAQ: VNDA) today announced that it will participate at the Citi 12th Annual Biotech Conference. Vanda will host
meetings at the Citi Biotech Conference in Boston on Thursday, September
7, 2017.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit www.vandapharma.com.
Company Contact:
Jim Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-the-citi-12th-annual-biotech-conference-300514948.html
SOURCE Vanda Pharmaceuticals Inc.